None listed
Conditions
Brief summary
Point prevalence study in India to identify sepsis prevalence in Indian ICUs In 2017, The World Health Organization recognised sepsis as a global health priority. The true disease burden of sepsis remains unknown as the current estimates of disease burden are largely based on the data from high income countries (HIC). Even though the majority of the global population lives in lower/middle income countries (LMICs), there is a scarcity of sepsis epidemiology data from LMICs. In countries such as India, 1 in 3 people who develop sepsis die. Many of these deaths are preventable but the epidemiology of sepsis is poorly understood. This problem is further compounded by a very high level of antimicrobial resistance. This study will provide up-to-date knowledge of the epidemiology and outcomes of sepsis, antibiotic use and antimicrobial resistance in intensive care units (ICUs) in Indian hospitals.
Interventions
A single-day, prospective, observational, multicentre, nation-wide point-prevalence study of sepsis in Indian Intensive Care Units. Data will be collected over a designated 24-hour study day, starting 08:00 am on the study day till 08:00 am on the following day. For ICUs participating in this study, a questionnaire to collect hospital- and ICU-level data will be administered along with individual patient data.Data analysis will be guided by a statistical analysis plan, which will be developed before the database is locked. Data analysis will be undertaken at the George Institute for Global Health by statisticians using a statistical software package. To address the primary objectives descriptive statistics will be used including univariate comparisons.
Sponsors
Eligibility
Inclusion criteria
All adult patients (18 years or older) present in the ICU at the start of the study day or admitted during the 24-hour study period will be included in the study sample
Exclusion criteria
NONE